Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 5/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.34 |
| ▸ | PPARG | P37231 | 7/20 | 0.34 |
| ▸ | PPARD | Q03181 | 7/20 | 0.34 |
| ▸ | PPARA | Q07869 | 7/20 | 0.34 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TLR2 | O60603 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | FABP4 | P15090 | 2/20 | 0.34 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.34 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL17080412 | 1.00 | GAA (0.37) | GAATSHRLMNANFKB1PMP22 | |
| SCHEMBL434149 | 0.98 | GAA (0.38) | GAATSHRLMNANFKB1PMP22 | |
| SCHEMBL9577728 | 0.98 | GAA (0.38) | GAATSHRLMNANFKB1PMP22 | |
| SCHEMBL431527 | 0.98 | GAA (0.38) | GAATSHRLMNANFKB1PMP22 | |
| Sebacic Acid SCHEMBL28872453 | 0.98 | GAA (0.38) | GAATSHRLMNANFKB1PMP22 | |
| SCHEMBL35143 | 0.98 | GAA (0.38) | GAATSHRLMNANFKB1PMP22 | |
| SCHEMBL9577600 | 0.97 | GAA (0.38) | GAATSHRLMNANFKB1PMP22 | |
| SCHEMBL315238 | 0.94 | GAA (0.38) | GAALMNASLC22A6KMT2AHTT | |
| SCHEMBL8226136 | 0.93 | GAA (0.35) | GAATSHRLMNANFKB1PMP22 | |
| SCHEMBL5955261 | 0.93 | GAA (0.35) | GAATSHRLMNANFKB1PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8101094-B2 | Terpene, terpenoid, and fullerene stabilizers for fluoroolefins | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-01-24 | — | — | US | claimed |
| US-9018420-B2 | Use of supported ionic liquid phase (SILP) catalyst systems in the hydroformylation of olefin-containing mixtures to aldehyde mixtures with a high content of aldehydes unbranched in the 2 position | EVONIK OXENO GMBH (DE) | 2015-04-28 | — | — | US | disclosed |
| US-20130289313-A1 | USE OF SUPPORTED IONIC LIQUID PHASE (SILP) CATALYST SYSTEMS IN THE HYDROFORMYLATION OF OLEFIN-CONTAINING MIXTURES TO ALDEHYDE MIXTURES WITH A HIGH CONTENT OF ALDEHYDES UNBRANCHED IN THE 2 POSITION | EVONIK OXENO GMBH (DE) | 2013-10-31 | — | — | US | disclosed |
| US-5705083-A | Stabilizing leather against thermal and photochemical decomposition | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130289313-A1 | USE OF SUPPORTED IONIC LIQUID PHASE (SILP) CATALYST SYSTEMS IN THE HYDROFORMYLATION OF OLEFIN-CONTAINING MIXTURES TO ALDEHYDE MIXTURES WITH A HIGH CONTENT OF ALDEHYDES UNBRANCHED IN THE 2 POSITION | OR10J3, H1-0, HRH4 | GAA 4195/4885TSHR 4595/4885LMNA 3699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.